Literature DB >> 33634914

Light chain myeloma and detection of free light chains in serum and urine of dogs and cats.

Robert Adam Harris1, Matthew Miller2, Dillon Donaghy1, Laura Ashton1, Catherine Langston2, Todd Shockey3, A Russell Moore1.   

Abstract

BACKGROUND: Detection of free light chains (fLC) in animals relies on protein electrophoresis or the Bence-Jones protein test on urine.
OBJECTIVE: To describe the detection of both serum fLC (sfLC) and urine fLC (ufLC) in 8 dogs and 2 cats using a commercially available human immunofixation (IF) kit. ANIMALS: Archived serum or urine samples from 27 dogs and 2 cats submitted to the Colorado State University Veterinary Diagnostic Laboratory for routine diagnostics.
METHODS: Retrospective study evaluating the presence of fLC in dogs and cats using agarose gel electrophoresis and routine and fLC IF performed on serum and urine. The performance of the fLC IF reagents was evaluated using samples characterized by routine IF, tandem mass spectrometry, and a combination of fLC IF and western blotting. Free light chains were documented by paired electrophoresis and fLC IF.
RESULTS: The fLC only myeloma case developed end-stage renal failure 5 months post initial diagnosis. All electrophoresis-defined urinary Bence-Jones proteins were labeled by the anti-free λ light chain (anti-fλ) reagent; none were labeled by the anti-free κ light chain (anti-fκ); 2 of these were identified as fκ by mass spectrometry. An electrophoretically identical protein restriction that was labeled by the anti-fλ reagent was present in the paired serum from 5/8 of cases, documenting sfLC. CONCLUSIONS AND CLINICAL IMPORTANCE: Commercially available human IF reagents identified sfLC and ufLC in both dogs and cats. Free light chains may be nephrotoxic in dogs.
© 2021 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals LLC on behalf of American College of Veterinary Internal Medicine.

Entities:  

Keywords:  Bence-Jones proteins; electrophoresis; gammopathy; immunoglobulin; proteinuria

Mesh:

Year:  2021        PMID: 33634914      PMCID: PMC7995444          DOI: 10.1111/jvim.16070

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  34 in total

1.  Early reduction of serum-free light chains associates with renal recovery in myeloma kidney.

Authors:  Colin A Hutchison; Paul Cockwell; Stephanie Stringer; Arthur Bradwell; Mark Cook; Morie A Gertz; Angela Dispenzieri; Jeffrey L Winters; Shaji Kumar; S Vincent Rajkumar; Robert A Kyle; Nelson Leung
Journal:  J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 10.121

2.  Light-chain myeloma in a dog.

Authors:  Elizabeth S Cowgill; Jennifer A Neel; David Ruslander
Journal:  J Vet Intern Med       Date:  2004 Jan-Feb       Impact factor: 3.333

Review 3.  Assigning significance to peptides identified by tandem mass spectrometry using decoy databases.

Authors:  Lukas Käll; John D Storey; Michael J MacCoss; William Stafford Noble
Journal:  J Proteome Res       Date:  2007-12-08       Impact factor: 4.466

4.  Identification of canine IgG and its subclasses, IgG1, IgG2, IgG3 and IgG4, by immunofixation and commercially available antisera.

Authors:  Dillon Donaghy; A Russell Moore
Journal:  Vet Immunol Immunopathol       Date:  2020-01-23       Impact factor: 2.046

5.  Serum free light chains: an alternative to the urine Bence Jones proteins screening test for monoclonal gammopathies.

Authors:  Peter G Hill; Julia M Forsyth; Baldeep Rai; Stewart Mayne
Journal:  Clin Chem       Date:  2006-07-20       Impact factor: 8.327

Review 6.  Achieving an early myeloma response in patients with kidney impairment.

Authors:  Stephanie Stringer; Mark Cook; Paul Cockwell
Journal:  Adv Chronic Kidney Dis       Date:  2012-09       Impact factor: 3.620

7.  The effects of hydrocortisone on systemic arterial blood pressure and urinary protein excretion in dogs.

Authors:  S Schellenberg; M Mettler; F Gentilini; R Portmann; T M Glaus; C E Reusch
Journal:  J Vet Intern Med       Date:  2008-02-27       Impact factor: 3.333

8.  Evaluation of various biomarkers for kidney monitoring during canine leishmaniosis treatment.

Authors:  Luis Pardo-Marín; Silvia Martínez-Subiela; Josep Pastor; Asta Tvarijonaviciute; Juan Diego Garcia-Martinez; Sergi Segarra; José Joaquín Cerón
Journal:  BMC Vet Res       Date:  2017-01-23       Impact factor: 2.741

9.  Serum free light chain levels and renal function at diagnosis in patients with multiple myeloma.

Authors:  Punit Yadav; Paul Cockwell; Mark Cook; Jennifer Pinney; Hannah Giles; Yu Sandar Aung; David Cairns; Roger G Owen; Faith E Davies; Graham H Jackson; J Anthony Child; Gareth J Morgan; Mark T Drayson
Journal:  BMC Nephrol       Date:  2018-07-13       Impact factor: 2.388

10.  Retrospective evaluation of the use of the International Myeloma Working Group response criteria in dogs with secretory multiple myeloma.

Authors:  A Russell Moore; Adam Harris; Christina Jeffries; Paul R Avery; Kate Vickery
Journal:  J Vet Intern Med       Date:  2020-11-20       Impact factor: 3.175

View more
  1 in total

1.  Light chain myeloma and detection of free light chains in serum and urine of dogs and cats.

Authors:  Robert Adam Harris; Matthew Miller; Dillon Donaghy; Laura Ashton; Catherine Langston; Todd Shockey; A Russell Moore
Journal:  J Vet Intern Med       Date:  2021-02-26       Impact factor: 3.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.